Archive for Февраль 23rd, 2007
January 19th FDA plans to approval of diet drug Acomplia (rimonabant) Zimulti name in USA
Merck reiterated on January. 19th that it plans to file for FDA approval of diet drug Acomplia (rimonabant) “Taranabant” in 2008 even though some adverse psychiatric side-effects have been observed similar to those found with Sanofi’s diet drug Acomplia (rimonabant).
Taranabant, a CB-1 receptor inverse agonist, and [...]
